Medigen vaccine data good but questions remain: Experts
06/11/2021 05:34 PM
CNA file photo
Taipei, June 11 (CNA) The Phase 2 clinical trial results of a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. generated good data, experts have said, but they cautioned there was still no way to know how effectively it will protect people against getting the disease. Data looks quite good, Academia Sinica academician Michael M.C. Lai (賴明詔), a reputed virologist and coronavirus researcher, told CNA on Thursday after Medigen announced that its vaccine candidate had shown no major safety concerns.
Lai said the published data showed the vaccine was able to produce sufficient neutralizing antibodies, and as long as there were antibodies, there should be protection, while also noting that its toxicity was low.
Phase 2 clinical trial results of a COVID-19 vaccine developed by Medigen Vaccine Biologics Corp generated good data, experts said, although they warned that there was still no way to know how effectively it would prevent the disease.
“Data look quite good,” Academia Sinica researcher Michael Lai (賴明詔) said on Thursday after Medigen announced that its vaccine candidate had shown no major safety concerns.
The data showed that the vaccine produced sufficient neutralizing antibodies and as long as there were antibodies, there should be protection, Lai said, adding that its toxicity was low.
The Medigen vaccine has achieved the goals of creating sufficient
Image taken from Unsplash for illustrative purposes only
Taipei, Dec. 17 (CNA) A Central Epidemic Command Center (CECC) official on Thursday cautioned the public against taking any unverified COVID-19 vaccine, after rumors surfaced that some Taiwanese businesspeople are planning to organize private groups to receive vaccinations in China, Hong Kong or Macau.
Not only will an unproven vaccine be ineffective against COVID-19, inoculation also runs the risk of serious illness, CECC expert Lee Ping-ing (李秉穎) said in a radio interview, adding that taking anything other than an internationally certified vaccine is highly inadvisable.
Lee, who is also honorary chairman at Taiwan Immunization Vision and Strategy, cautioned that a plethora of vaccines are currently in development in China, many of which are still in phase one or two of clinical trials.
Travel to China to get vaccine discouraged taipeitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taipeitimes.com Daily Mail and Mail on Sunday newspapers.